Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adenocarcinoma
Glycodelin reduces endometrial adenocarcinoma-associated gene expression
February 23rd, 2006
According to recent research from Finland published in the American Journal of Obstetrics and Gynecology, glycodelin reduces carcinoma-associated gene expression in endometrial adenocarcinoma cells. "Glycodelin is a major secretory glycoprotein of differentiated endometrial epithelium, rarely expressed in proliferative endometrium or endometrial cancer. We aimed to elucidate its role in growth and gene expression of endometrial adenocarcinoma cells, and hypothesized that glycodelin affects cell growth and tumor-associated gene expression," wrote H. Koistinen and colleagues, University of Helsinki. "Endometrial adenocarcinoma, HEC-1B cells were...
Source: Women's Health Weekly (2006-02-23)
|
